REG - Futura Medical PLC - TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES <Origin Href="QuoteRef">FUM.L</Origin>
RNS Number : 1563PFutura Medical PLC03 June 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:Futura Medical plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
Change in our Terms & Conditions restricting the exercise of Voting Rights to Discretionary client holdings
X
3. Full name of person(s) subject to the
notification obligation:Investec Wealth & Investment Limited
4. Full name of shareholder(s)
(if different from 3.):N/A
5. Date of the transaction and date on
which the threshold is crossed or
reached:1st June 2015
6. Date on which issuer notified:
3rd June 2015
7. Threshold(s) that is/are crossed or
reached:Below 1%
8. Notified details:
A: Voting rights attached to shares
Class/type of
shares
if possible using
the ISIN CODESituation previous
to the triggering
transactionResulting situation after the triggering transaction
Number
of
SharesNumber
of
Voting
RightsNumber
of sharesNumber of voting
rights% of voting rights
Direct
Direct
Indirect
Direct
Indirect
Ordinary Shares
3,378,902
3,378,902
773,142
773,142
0.78%
GB0033278473
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrumentExpiration
dateExercise/
Conversion PeriodNumber of voting
rights that may be
acquired if the
instrument is
exercised/ converted.% of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrumentExercise price
Expiration date
Exercise/
Conversion periodNumber of voting rights instrument refers to
% of voting rights
Nominal
Delta
Total (A+B+C)
Number of voting rights
Percentage of voting rights
773,142
0.78%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:Discretionary client holdings registered in the name of Nominee companies 100% owned by Investec Wealth & Investment Limited.
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease
to hold:
N/A
12. Date on which proxy holder will cease to hold
voting rights:
N/A
13. Additional information:
N/A
14. Contact name:
Phil Beardwell Chartered FCSI
Senior Compliance Manager
15. Contact telephone number:
020 7597 1356
This information is provided by RNSThe company news service from the London Stock ExchangeENDHOLLLFLRRSIVIIE
Recent news on Futura Medical
See all newsREG - Futura Medical PLC - Positive Eroxon® & Eroxon® “Intense” HUT results
AnnouncementREG - Futura Medical PLC - Formal Grant of US Patent
AnnouncementREG - Futura Medical PLC - Holding(s) in Company
AnnouncementREG - Futura Medical PLC - Holding(s) in Company
AnnouncementREG - Futura Medical PLC - Patent notice of allowance granted for the US
Announcement